Assessment of the long-term visual and anatomical outcomes of ranibizumab to treat neovascular age-related macular degeneration

Journal Title: International Journal of Ophthalmology - Year 2018, Vol 11, Issue 4

Abstract

"AIM: To investigate the long-term visual and anatomical outcomes of patients who underwent intravitreal ranibizumab monotherapy to treat neovascular age-related macular degeneration (AMD) and followed-up for at least 2y. METHODS: A total of 74 eyes of 74 patients who underwent ranibizumab monotherapy for neovascular AMD were included in this retrospective study. RESULTS: The average patient age was 72.1±6.5 (range, 57-85)y, the average follow-up time 46.2±13.1 (range, 24-75)mo, and the average number of visits 24.1±9.5 (range, 8-48). The mean number of injections in year 1 was 4.5, 1.6 in year 2, 0.9 in year 3, 0.4 on year 4, and 0.1 in the following years. Within the entire follow-up period, the mean number of injections was 7.6±4.4 (range, 2-21). The mean visual acuity was 48.1±15 (range, 15-76) letters at baseline and 45.7±19 (range, 7-75) at year 5. The mean central macular thickness was 303±78 (range, 178-552) µm at baseline and 251±51 (range, 138-359) µm at year 5. Scars developed in 47 (63.5%) eyes at the end of the follow-up period, and atrophy was evident in 6 (8.1%) eyes. CONCLUSION: Ranibizumab monotherapy can stabilize visual acuity for a mean period of 4y in patients with neovascular AMD."

Authors and Affiliations

Keywords

Related Articles

Scutellaria barbata attenuates diabetic retinopathy by preventing retinal inflammation and the decreased expression of tight junction protein

"AIM: To observe the attenuation of ethanol extract of Herba Scutellaria barbata (SE) against diabetic retinopathy (DR) and its engaged mechanism. METHODS: C57BL/6J mice were intraperitoneally injected with streptozotoci...

Long-term outcomes of uveitic glaucoma treated with Ahmed valve implant in a series of Chinese patients

"AIM: To report long-term outcomes of secondary glaucoma due to uveitis treated with Ahmed glaucoma valve (AGV) implantation in a series of Chinese patients. METHODS: The retrospective study included 67 eyes from 56 pati...

The ocular toxicity and pharmacokinetics of simvastatin following intravitreal injection in mice

"AIM: To investigate the retinal toxicity and pharmacokinetics of simvastatin intravitreally injected into mice. METHODS: Forty-eight 6-8-week-old C57BL/6J mice were used in this study. Simvastatin was intravitreally inj...

Mode of delivery, birth weight and the incidence of congenital nasolacrimal duct obstruction

"AIM: To study any possible association of congenital nasolacrimal duct obstruction (CNLDO) with mode of delivery, birth weight and gestational age. METHODS: We retrospectively reviewed charts of all patients (n=2591) un...

Download PDF file
  • EP ID EP491309
  • DOI 10.18240/ijo.2018.04.18
  • Views 37
  • Downloads 0

How To Cite

(2018). Assessment of the long-term visual and anatomical outcomes of ranibizumab to treat neovascular age-related macular degeneration. International Journal of Ophthalmology, 11(4), -. https://europub.co.uk/articles/-A-491309